Authors: MARINELLI M BARROT M SIMON H OBERLANDER C DEKEYNE A LEMOAL M PIAZZA PV

Citation: M. Marinelli et al., PHARMACOLOGICAL STIMULI DECREASING NUCLEUS-ACCUMBENS DOPAMINE CAN ACTAS POSITIVE REINFORCERS BUT HAVE A LOW ADDICTIVE POTENTIAL, European journal of neuroscience, 10(10), 1998, pp. 3269-3275

Authors: MILLAN MJ DEKEYNE A GOBERT A

Citation: Mj. Millan et al., SEROTONIN (5-HT)(2C) RECEPTORS TONICALLY INHIBIT DOPAMINE (DA) AND NORADRENALINE (NA), BUT NOT 5-HT, RELEASE IN THE FRONTAL-CORTEX IN-VIVO, Neuropharmacology, 37(7), 1998, pp. 953-955

Authors: MILLAN MJ NEWMANTANCREDI A BROCCO N GOBERT A LEJEUNE F AUDINOT V RIVET JM SCHREIBER R DEKEYNE A SPEDDING M NICOLAS JP PEGLION JL

Citation: Mj. Millan et al., S-18126 4-(2,3-DIHYDROBENZO[1,4]DIOXIN-6-YL)PIPERAZIN-1-YL METHYL]INDAN-2-YL)), A POTENT, SELECTIVE AND COMPETITIVE ANTAGONIST AT DOPAMINE D-4 RECEPTORS - AN IN-VITRO AND IN-VIVO COMPARISON WITH L-745,870 YL]PIPERAZIN-1-YL)METHYL-1H-PYRROLO[2,3B]PYRIDINE) AND RACLOPRIDE, The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 167-186

Authors: AUDINOT V NEWMANTANCREDI A GOBERT A RIVET JM BROCCO M LEJEUNE F GLUCK L DESPOSTE I BERVOETS K DEKEYNE A MILLAN MJ

Citation: V. Audinot et al., A COMPARATIVE IN-VITRO AND IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL DOPAMINE D-3 RECEPTOR ANTAGONISTS (-S-14297, NAFADOTRIDE, GR-103,691 AND U-99194()), The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 187-197

Authors: MILLAN MJ SCHREIBER R DEKEYNE A RIVET JM BERVOETS K MAVRIDIS M SEBBAN C MAURELREMY S NEWMANTANCREDI A SPEDDING M MULLER O LAVIELLE G BROCCO M

Citation: Mj. Millan et al., S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL, POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - II - FUNCTIONAL PROFILE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL, The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1356-1373